{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-021278","form_type":"8-K","ticker":"CRVO","cik":"0001053691","company_name":"CervoMed Inc.","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.338783+00:00","generated_at":"2026-05-18T18:55:03.098645+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"CervoMed stockholders elect seven directors and approve 2025 equity plan at annual meeting","bullets":["All seven director nominees elected; John Alam received 3,923,241 votes for, 21,554 withheld.","Ratification of RSM US LLP as auditor approved: 5,571,505 for, 25,008 against, 13,724 abstain.","Advisory vote on 2024 executive compensation approved with 3,891,229 for, 33,195 against, 20,371 abstain.","CervoMed 2025 Equity Incentive Plan approved: 3,798,568 for, 137,758 against, 8,469 abstain.","Approximately 5.61 million shares voted, representing 64.5% of outstanding shares; all proposals passed."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-021278","json":"https://secwatch.observer/filing/0001437749-25-021278.json","markdown":"https://secwatch.observer/filing/0001437749-25-021278.md","text":"https://secwatch.observer/filing/0001437749-25-021278.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021278/0001437749-25-021278-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021278/crvo20250625_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T18:55:03.098645+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}